✨ Your Portfolio is fetched and updated from zerodha.
Nano Miscellaneous

Sunrest Lifescience Ltd.

SUNREST

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹18 Cr.
P/E
9.20

Sunrest Lifescience Ltd.

  • Sunrest Lifescience
  • Shanthala FMCG Prod
  • Dalmia Indl. Dev

FAQs on Sunrest Lifescience Ltd. Shareprice

Sunrest Lifescience has given lower returns compared to its competitors.
Sunrest Lifescience has grown at ~-20.48% over the last 2yrs while peers have grown at a median rate of -2.79%

Sunrest Lifescience is not expensive.
Latest PE of Sunrest Lifescience is 9.2, while 3 year average PE is 55.89.
Also latest EV/EBITDA of Sunrest Lifescience is 5.65 while 3yr average is 11.8.

View FAQ's On Business

Growth Table

  • Sunrest Lifescience Ltd.
  • Shanthala FMCG Prod
  • Dalmia Indl. Dev

Balance Sheet

  • Sunrest Lifescience Ltd.
  • Shanthala FMCG Prod
  • Dalmia Indl. Dev

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Sunrest Lifescience Ltd.
  • Shanthala FMCG Prod
  • Dalmia Indl. Dev

Cash Flow

  • Sunrest Lifescience Ltd.
  • Shanthala FMCG Prod
  • Dalmia Indl. Dev

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Sunrest Lifescience Ltd.
  • Shanthala FMCG Prod
  • Dalmia Indl. Dev

Quarterly Results

  • Sunrest Lifescience Ltd.
  • Shanthala FMCG Prod
  • Dalmia Indl. Dev

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Sunrest Lifescience Ltd. Financials

Sunrest Lifescience balance sheet is weak and might have solvency issues

Yes, The net debt of Sunrest Lifescience is increasing.
Latest net debt of Sunrest Lifescience is ₹14.69 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹9.04 Crs.

The profit is oscillating.
The profit of Sunrest Lifescience is ₹1.24 Crs for TTM, ₹2.01 Crs for Mar 2025 and ₹0.23 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Sunrest Lifescience latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech